1 |
Long J, Sang X, Zhao H. Association of chronic liver disease with the prognosis of COVID-19 patients. J Hepatol 2021:S0168-8278(21)01910-3. [PMID: 34293343 DOI: 10.1016/j.jhep.2021.07.011] [Reference Citation Analysis]
|
2 |
Middleton P, Hsu C, Lythgoe MP. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterol 2021;8:e000739. [PMID: 34675033 DOI: 10.1136/bmjgast-2021-000739] [Reference Citation Analysis]
|
3 |
Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
|
4 |
Giabicani M, Le Menestrel A, Roux O, Rautou PE, Weiss E; COVID-ICU study group. Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: a case control study from the prospective COVID-ICU database. J Hepatol 2021:S0168-8278(21)02080-8. [PMID: 34600975 DOI: 10.1016/j.jhep.2021.09.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Elhence A, Vaishnav M, Biswas S, Anand A, Gunjan D, Kedia S, Mahapatra SJ, Nayak B, Sheikh S, Soni KD, Trikha A, Goel A, Shalimar. Predictors of in-hospital outcomes in patients with Cirrhosis and Coronavirus disease-2019. J Clin Exp Hepatol 2021. [PMID: 34728983 DOI: 10.1016/j.jceh.2021.10.014] [Reference Citation Analysis]
|
6 |
Depret F, Bouam S, Schwarzinger M, Mallet V; Demosthenes research group. Reply to: "Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database". J Hepatol 2021:S0168-8278(21)02225-X. [PMID: 34838613 DOI: 10.1016/j.jhep.2021.11.020] [Reference Citation Analysis]
|